Consistent with our findings, increased expression of PAI-1 by the tumor stroma correlates with poor prognosis in ESCC [27] and breast cancer patients [46], but no reports have evaluated the immunohistochemical expression intensity of both PAI-1 and LRP1 in tumor tissues. This evidence concerns the gene LRP1 and neoplasm.